Corrigendum: Myelodysplastic syndrome/acute myeloid leukemia following the use of poly-ADP ribose polymerase inhibitors: A real-world analysis of postmarketing surveillance data. [PDF]
Zhao Q +6 more
europepmc +1 more source
Pharmacodynamic analysis of hypertension caused by lenvatinib using real-world postmarketing surveillance data. [PDF]
Otani Y, Kasai H, Tanigawara Y.
europepmc +1 more source
Malignancies in children and young adults on etanercept: summary of cases from clinical trials and post marketing reports [PDF]
core +1 more source
Effectiveness, safety, and methotrexate dose-tapering pattern over two years of treatment with adalimumab and ≥12 mg/week methotrexate for early rheumatoid arthritis: Results of the HAWK postmarketing surveillance study in Japan [PDF]
Yoshiya Tanaka +6 more
openalex +1 more source
Postmarketing surveillance of brentuximab vedotin for previously untreated Hodgkin lymphoma in Japanese patients. [PDF]
Okazuka K +5 more
europepmc +1 more source
Postmarketing surveillance: practical experience with ketotifen. [PDF]
W. P. Maclay +3 more
openalex +1 more source
Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real-World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data. [PDF]
Rahurkar S +8 more
europepmc +1 more source
Long-term effectiveness of Gliadel implant for malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in Japan. [PDF]
Iuchi T +10 more
europepmc +1 more source
Real-world evaluation of interstitial lung disease/pneumonitis in patients treated with trastuzumab deruxtecan for HER2-positive advanced or recurrent gastric cancer: a postmarketing surveillance study in Japan. [PDF]
Kawakami H +3 more
europepmc +1 more source
Myelodysplastic Syndrome/Acute Myeloid Leukemia Following the Use of Poly-ADP Ribose Polymerase (PARP) Inhibitors: A Real-World Analysis of Postmarketing Surveillance Data. [PDF]
Zhao Q +6 more
europepmc +1 more source

